British Airways Pensions Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

British Airways Pensions Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,398	Closed	-$9.74M	–	115
2020 Q3	$9.74M	Sell	17,398 -6,175	-26%	-$3.74M	0.39%	75
2020 Q2	$14.7M	Sell	23,573 -516	-2%	-$293K	0.64%	33
2020 Q1	$11.8M	Buy	+24,089	New	+$9.94M	0.62%	36
2016 Q4	–	Sell	-45,403	Closed	-$18.2M	–	127
2016 Q3	$18.2M	Sell	45,403 -41	-0.1%	-$16.4K	0.54%	81
2016 Q2	$15.9M	Hold	45,444	–	–	0.48%	81
2016 Q1	$16.4M	Hold	45,444	–	–	0.51%	82
2015 Q4	$24.7M	Sell	45,444 -6,500	-13%	-$3.52M	0.77%	55
2015 Q3	$24.2M	Sell	51,944 -8,440	-14%	-$4.53M	0.82%	49
2015 Q2	$30.8M	Buy	60,384 +9,050	+18%	+$4.42M	0.95%	37
2015 Q1	$23.2M	Hold	51,334	–	–	0.71%	71
2014 Q4	$21.1M	Buy	+51,334	New	+$20.2M	0.69%	68

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

British Airways Pensions Investment Management's REGN Position: Q4 2020 in Review

British Airways Pensions Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2020, closing a stake of 17,398 shares — an estimated $9.74M sold.

British Airways Pensions Investment Management first reported a position in REGN in Q4 2014 and held it in 11 quarters. The position peaked at $30.8M in Q2 2015. 904 funds tracked by Wall St. Rank hold REGN as of Q4 2020.

British Airways Pensions Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
British Airways Pensions Investment Management sold 17,398 Regeneron Pharmaceuticals shares in Q4 2020, an estimated $9.74M.
British Airways Pensions Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 11 quarters.
British Airways Pensions Investment Management's Regeneron Pharmaceuticals position peaked at $30.8M in Q2 2015.
904 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2020.

Based on British Airways Pensions Investment Management's 13F filing for Q4 2020, filed 22 Jan 2021.